Boise, ID, United States of America

Steve Testardi

This inventor holds 2 USPTO granted patents. Top assignee: Hewlett-Packard Development Company, L.p.. Active years: 2012-2014.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Steve Testardi: Innovator in Electro-Photographic Technology

Introduction

Steve Testardi is a notable inventor based in Boise, ID (US). He has made significant contributions to the field of electro-photographic technology, holding 2 patents that showcase his innovative approach to reducing wear on printer components.

Latest Patents

Testardi's latest patents focus on methods for enhancing the longevity of electro-photographic printer drums. One of his patents describes a method for reducing wear on an electro-photographic printer drum. This method includes determining a non-image region of a page to be printed, applying a halftone pattern of toner to the corresponding portion of the printer drum, and rotating the drum against a cleaning blade. The halftone pattern of toner serves to provide lubrication between the drum and the cleaning blade, thereby minimizing wear.

Career Highlights

Steve Testardi is currently employed at Hewlett-Packard Development Company, L.P. His work at HP has allowed him to focus on developing innovative solutions that improve the efficiency and durability of printing technologies.

Collaborations

One of his notable coworkers is Anthony Peter Holden. Their collaboration has likely contributed to advancements in the field of electro-photographic printing.

Conclusion

Steve Testardi's contributions to the field of electro-photographic technology through his patents and work at Hewlett-Packard highlight his role as an innovator in the industry. His methods for reducing wear on printer drums are a testament to his commitment to enhancing printing technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…